Target intelligence / Profile preview

Calcium release-activated calcium channel protein 3 (ORAI3)

Target
ORAI3
Molecular classification
Ion channel, Store-operated calcium channel (SOCC), Transmembrane protein
01

Overview

Calcium release-activated calcium channel protein 3 (ORAI3) is a member of the Orai family of transmembrane proteins, which forms highly Ca²⁺-selective channels in the plasma membrane. ORAI3 contributes to store-operated calcium entry (SOCE), responding to ER calcium depletion primarily through STIM1 interaction. It displays unique features distinct from its relatives (Orai1, Orai2), including specialized gating, selectivity, and regulation, and can form heteromeric channels with Orai1. In cardiac tissue, ORAI3 is essential for maintaining sarcomere structure, mitochondrial integrity, and normal cardiac signaling; loss of ORAI3 is linked with severe heart disease. In non-excitable cells, including some cancer cell lines, ORAI3-mediated SOCE is crucial for cell proliferation and survival, implicating it in cancer biology and targeted therapies.

Other names
Orai3Protein orai-3Transmembrane protein 142CTMEM142CMGC13024
02

Mechanism of action

Modulation of Ca²⁺ influx via channel inhibition or activation; Alteration of proliferative or apoptotic signaling by regulating calcium entry

03

Biological functions

Calcium signalingStore-operated calcium entry (SOCE)Regulation of cell cycleCell proliferationApoptosisCardiac muscle contractionMitochondrial function
04

Disease associations

CancerCardiovascular disease (notably heart failure, dilated cardiomyopathy)Cell proliferation/survival (especially breast cancer)Cellular stress response
05

Safety considerations

Cardiotoxicity: Deletion or inhibition may cause severe cardiac dysfunction, including heart failure and dilated cardiomyopathyDisturbed calcium homeostasis: unwanted effects on cell proliferation, apoptosis, or mitochondrial function
06

Interacting drugs

2-aminoethoxydiphenyl borate (2-APB), a modulator/inhibitor

2 more in the full profile.

07

Biomarkers

ORAI3 expression (as a biomarker for breast cancer proliferation, especially in ER⁺ lines)Cardiac structure/function (marker for heart failure or dilated cardiomyopathy)

Beyond the preview

Go deeper on Calcium release-activated calcium channel protein 3 (ORAI3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium release-activated calcium channel protein 3 (ORAI3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call